Watch VideoAstraZeneca's CEO says the company needs to conduct another global trial for its vaccine. That's according to a report from Bloomberg.
AstraZeneca initially said its vaccine showed 62 percent effectiveness when taken as a full two-dose regimen.
It also said the vaccine was up to 90 percent effective when...
Bloomberg: AstraZeneca Wants To Hold Another Vaccine Trial
Newsy
0 shares
1 views
You might like
Related news coverage
AstraZeneca Likely To Run New Global Trial Of COVID-19 Vaccine
RTTNews
AstraZeneca is mulling an additional global trial to confirm the 90% efficacy rate of its Covid-19 vaccine candidate at lower..
-
AstraZeneca mulls new coronavirus vaccine trial following results confusion
Proactive Investors
-
Asian stocks mixed amid unease about vaccine development
SeattlePI.com
-
Asian stocks fall amid unease about vaccine development
SeattlePI.com
-
CEO says AstraZeneca likely to run new global trial of COVID-19 vaccine: Bloomberg News
Upworthy